1-5 of 5
Mary-Beth M. Percival
Close
Sort by
Journal Articles

Aspacytarabine (BST-236) As Monotherapy Is Safe, Well-Tolerated and Effective for the Treatment of Adults with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Therapy. Results of a Phase 2 Study

Jessica K. Altman, Jamie Koprivnikar, James K McCloskey, Vamsi Kota, Michael Keng, Dale L. Bixby, Olga Frankfurt, Ashkan Emadi, Tsila Zuckerman, Micah M. Burch, Moshe Y. Levy, Selina M. Luger, Bhavana Bhatnagar, Ofir Wolach, Chezi Ganzel, Mary-Beth M. Percival, Gail J. Roboz, Michael Craig, Itai Levi, Anna Gourevitch, Liat Flaishon, Darrel P. Cohen, Shoshi Tessler, Chen Blumberg, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe
Journal: Blood
Blood (2021) 138 (Supplement 1): 1273.
https://doi.org/10.1182/blood-2021-149361
Published: 2021
Journal Articles

Multiparameter Flow Cytometry (MFC) of Cerebrospinal Fluid (CSF) from Adults Receiving Hypercvad for Acute Lymphoblastic Leukemia/Lymphoma (ALL) Identifies Patients at Higher Risk of Central Nervous System (CNS) Relapse: A Single-Center Retrospective Analysis

Kelsey-Leigh A Garcia, Philip A. Stevenson, MS, Sindhu Cherian, MD, Christen N. Martino, NP, Andrei R Shustov, MD, Pamela S. Becker, MDPhD, Mary-Beth M. Percival, MD, Vivian G. Oehler, MD, Anna B. Halpern, MD, Roland P Walter, MDPhD, Johnnie Orozco, MD, Colin D. Godwin, MDMPhil, Sioban Keel, MD, Elihu H. Estey, MD, Ryan D. Cassaday, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–30.
https://doi.org/10.1182/blood-2020-137780
Published: 2020
Journal Articles

Use of Gemtuzumab Ozogamicin for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) or Acute Promyelocytic Leukemia (APL) in an Expanded Access Setting at Our Cancer Consortium

Kelda M Gardner, PA-C, Kathleen Shannon Dorcy, PhD RN, Rachele O'Leary, Donelle Rizzuto, RN, Roland B. Walter, MD PhD MS, Carole Shaw, Sunny So, RN, Paul C. Hendrie, MD PhD, Bart L Scott, MD, Mary Beth M. Percival, MD, Anna B. Halpern, MD, Ryan D. Cassaday, MD, Janis L. Abkowitz, MD, Bethany Murphy, Niall Curley, Cody Hammer, Heather Smith, PA-C, Gabrielle A Zecha, PA-C, Frederick R. Appelbaum, MD, Soheil Meshinchi, MD PhD, Colleen Delaney, MDMSc, Todd M Cooper, DO, Katherine Tarlock, MD, Elihu H. Estey, MD, Pamela S. Becker, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2710.
https://doi.org/10.1182/blood-2018-99-116908
Published: 2018
Journal Articles

Outpatient Intensive Induction Chemotherapy for Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome

Frances Linzee Mabrey, MD, Kelda M Gardner, PA-C, Kathleen Shannon Dorcy, RN, PhD, Andrea Perdue, PA-C, Heather Smith, PA-C, Alicyn Marie Davis, ARNP, Cody Hammer, Donelle Rizzuto, RN, Sunny So, RN, Anna Rosen, Kim Quach, Bart L. Scott, MD, Paul C. Hendrie, MD PhD, Mary Beth M. Percival, MD, Roland B. Walter, MD PhD MS, Frederick R. Appelbaum, MD, Elihu H. Estey, MD, Pamela S. Becker, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3851.
https://doi.org/10.1182/blood.V130.Suppl_1.3851.3851
Published: 2017
Journal Articles

TTI-621 (SIRPαFc), an Immune Checkpoint Inhibitor Blocking the CD47 “Do Not Eat” Signal, Induces Objective Responses in Patients with Advanced, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Stephen M Ansell, MD PhD, Ian W. Flinn, MD PhD, Michael B. Maris, MD, Owen A. O'Connor, MD, PhD, Alexander Lesokhin, MD, Anjali S. Advani, MD, Mark D. Minden, MD PhD, Mary Beth M. Percival, MD, Lisa DS Johnson, PhD, Tina Catalano, MSc, Meghan Irwin, BSc, EMBA, Penka S. Petrova, PhD, Robert A. Uger, PhD, Eric L Sievers, MD, Robert W. Chen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4116.
https://doi.org/10.1182/blood.V130.Suppl_1.4116.4116
Published: 2017